17 Facts About Agilent Technologies

Agilent Technologies, Inc is an American life sciences company that provides instruments, software, services, and consumables for the entire laboratory workflow.

Agilent Technologies was established in 1999 as a spin-off from Hewlett-Packard.

The resulting IPO of Agilent Technologies stock was the largest in the history of Silicon Valley at the time.

Agilent Technologies focuses its products and services on six markets: food, environmental and forensics, pharmaceutical, diagnostics, chemical and energy, and research.

Agilent Technologies serves analytical laboratories and the clinical and routine diagnostics markets with a full suite of technology platforms.

Related searches

Agilent Technologies provides the lab management services including subscription based services, and lab supplies: enterprise asset management, laboratory business intelligence, equipment management and service, software maintenance, regulatory compliance, sample preparation, genomics and cloning, GC and HPLC columns, spectrometry and spectroscopy supplies, and general laboratory supplies.

Agilent Technologies was created in 1999 by the spin-off of Hewlett-Packard's "Medical Products and Instrument Group", including instrumentation and chemical analysis, electronic components, and medical equipment product lines.

The starburst logo was selected to reflect "a burst of insight" and the name "Agilent Technologies" aimed to invoke the notion of agility as a trait of the new firm.

The Agilent Technologies spin-off was accompanied by an initial public offering which raised $2.

In 2001, in midst of this downsizing, Agilent Technologies sold its health care and medical products organization to Philips Medical Systems, and was noted as having a valuation of about $11 billion.

Also in August 2005, Agilent Technologies announced a plan to divest its semiconductor test business, composed of both the system-on-chip and memory test market areas.

Agilent Technologies listed the new company as Verigy on NASDAQ in mid-2006.

Agilent Technologies announced it would increase its life sciences engagement through the acquisition of Halo Genomics, based in Uppsala, Sweden, which was involved in next-generation sequencing technology development.

On May 17, 2012, Agilent Technologies agreed to buy Dako, a Danish cancer diagnostics company, for $2.

On September 19, 2013, Agilent Technologies announced its decision to separate into two publicly traded companies: Agilent Technologies, a life sciences, diagnostics, and applied markets company, and an electronic measurement company.

On November 1, 2014, in a special dividend distribution of all outstanding shares of Keysight's common stock, Agilent Technologies shareholders received one share of Keysight common stock for every two shares of Agilent Technologies common stock held as of close of business October 22, 2014.

On July 7, 2016, Agilent announced that they had acquired U K based Cobalt Light Systems, which develops and manufactures Raman spectroscopy instruments, for £40 million in cash.